Exploring how specific genes affect Alzheimer's disease and brain signaling.

UNDERSTANDING THE ROLE OF TM2D FAMILY GENES IN NOTCH SIGNALING AND ALZHEIMER'S DISEASE

NIH-funded research Baylor College of Medicine · NIH-11077858

This study is looking at how certain genes might affect the risk of developing Alzheimer's disease by using fruit flies to learn more about a key protein in the brain, and it aims to find new ways to help people with the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11077858 on NIH RePORTER

What this research studies

This research investigates the role of TM2D family genes in the development of Alzheimer's disease (AD) by examining their impact on a critical protein involved in brain signaling. Using fruit flies as a model organism, the study aims to uncover how genetic variations in these genes contribute to the risk of developing late-onset AD. By understanding the molecular mechanisms at play, researchers hope to identify potential targets for therapeutic intervention. The collaboration with the CHARGE consortium enhances the study's depth by integrating genetic data from diverse populations.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or diagnosed with Alzheimer's disease.

Not a fit: Patients with early-onset Alzheimer's disease or those without genetic risk factors for the disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights into Alzheimer's disease mechanisms and potential therapeutic targets, improving treatment options for patients.

How similar studies have performed: Previous research has shown promise in understanding genetic factors in Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.